NCT00270881View on ClinicalTrials.gov

Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2011

Conditions
Acute Myelogenous LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous LeukemiaMyelodysplastic Syndrome
Interventions
PROCEDURE

Cord blood transplantation

unrelated cord blood transplantation

RADIATION

TBI

Total body irradiation (TBI) 12Gy

DRUG

cyclophosphamide

cyclophosphamide 120mg/kg

DRUG

cytarabine

cytarabine 3g/m2x4

Trial Locations (1)

160-8582

Keio University School of Medicine, Tokyo

All Listed Sponsors
lead

Keio University

OTHER

NCT00270881 - Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies | Biotech Hunter | Biotech Hunter